Skip to content
Peptide research

GHK

Also known as Tripeptide GHK · Liver Cell Growth Factor · Tripeptide-1
Category
Skin & Cosmetic
Administration routes
Topical
Regulatory status
Not FDA-approved

What it is

A naturally occurring copper-binding tripeptide marketed for wound healing, skin anti-aging, and anti-inflammatory effects via switching on thousands of genes in damaged tissue. Strongest evidence is animal and lab work on the copper-bound form (GHK-Cu); GHK alone has almost no human trials, no long-term safety data, and no established dosing. Supply is unregulated. Not an FDA-approved drug.

Read Full record

Studied uses & evidence

Studied uses(10)

  • Gene expression modulation (4,000+ genes)

    Low

    Derived from one human cell-line gene expression dataset, mostly unvalidated experimentally.

  • Wound healing and tissue regeneration

    Speculative

    Shown for the related compound GHK-Cu, not directly tested for copper-free GHK in humans.

  • Anti-inflammatory action

    Low

    Reduces inflammatory markers in animal and cell studies, not yet tested in a human trial.

Evidence limits

Evidence Level
Limited Clinical

Over 50 years of research since 1973 discovery. Broad Institute gene profiling confirms modulation of 4,000+ genes. Multiple 12-week placebo-controlled human trials for topical skin applications (using GHK-Cu). Extensive animal wound healing data across 5+ species. Anti-cancer and COPD gene reversal data from genomic analyses. Cognitive improvement in aged mice. Most clinical human studies used the copper-complexed form (GHK-Cu); GHK alone has strong in vitro and genomic evidence but fewer standalone human trials.

Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)

Cautions & risk summary

General cautions

  • Pregnancy or breastfeeding

    Absolute

    No human reproductive safety data exists for this peptide. Effects on fetal development are unknown.

  • Children under 18

    Absolute

    No pediatric safety data. Not recommended for use in minors.

  • Known hypersensitivity

    Absolute

    Discontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).

Risk summary(8)

Risks = level of concern: High · Moderate · Low · Theoretical

  • Very limited human clinical data for GHK alone (most studies use GHK-Cu copper complex)

    High
  • Research-grade GHK peptide may not meet pharmaceutical purity standards — quality varies among unregulated products sold online

    Moderate
  • Sensitive to carboxypeptidase degradation, particularly in wound environments — rapid breakdown limits bioavailability

    Moderate
  • Long-term systemic safety data in humans is lacking (no large-scale injectable trials)

    High
  • Gene modulation data is primarily from Broad Institute Connectivity Map computational analysis, not all validated in vivo

    High
  • GHK alone may have reduced efficacy compared to GHK-Cu for applications requiring copper delivery (antioxidant, wound healing)

    Moderate
  • No standardized dosing protocols established for oral or injectable GHK (without copper) in humans

    High
  • Theoretical concern: broad gene modulation (4,000+ genes) could have unintended effects not yet characterized

    Theoretical
Safety & interactions in Full record

Further reading

Read Full record

This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer

Compiled from published research indexed through March 2026.